These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30854249)

  • 1. Live-cell phenotypic-biomarker microfluidic assay for the risk stratification of cancer patients via machine learning.
    Manak MS; Varsanik JS; Hogan BJ; Whitfield MJ; Su WR; Joshi N; Steinke N; Min A; Berger D; Saphirstein RJ; Dixit G; Meyyappan T; Chu HM; Knopf KB; Albala DM; Sant GR; Chander AC
    Nat Biomed Eng; 2018 Oct; 2(10):761-772. PubMed ID: 30854249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Artificial Intelligence/Machine Vision & Learning for the Development of a Live Single-cell Phenotypic Biomarker Test to Predict Prostate Cancer Tumor Aggressiveness.
    Varsanik JS; Manak MS; Whitfield MJ; Hogan BJ; Su WR; Jiang CJ; Sant GR; Albala DM; Chander AC
    Rev Urol; 2020; 22(4):159-167. PubMed ID: 33927573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Proof-of-concept of a Novel Platform Utilizing Biopsy-derived Live Single Cells, Phenotypic Biomarkers, and Machine Learning Toward a Precision Risk Stratification Test for Prostate Cancer Grade Groups 1 and 2 (Gleason 3 + 3 and 3 + 4).
    Albala D; Manak MS; Varsanik JS; Rashid HH; Mouraviev V; Zappala SM; Ette E; Kella N; Rieger-Christ KM; Sant GR; Chander AC
    Urology; 2019 Feb; 124():198-206. PubMed ID: 30312670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.
    Katafigiotis I; Tyritzis SI; Stravodimos KG; Alamanis C; Pavlakis K; Vlahou A; Makridakis M; Katafigioti A; Garbis SD; Constantinides CA
    BJU Int; 2012 Dec; 110(11 Pt B):E688-93. PubMed ID: 23020913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving diagnostic recognition of primary hyperparathyroidism with machine learning.
    Somnay YR; Craven M; McCoy KL; Carty SE; Wang TS; Greenberg CC; Schneider DF
    Surgery; 2017 Apr; 161(4):1113-1121. PubMed ID: 27989606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Accuracy of Different Machine Learning Algorithms for Breast Cancer Risk Calculation: a Meta-Analysis.
    Nindrea RD; Aryandono T; Lazuardi L; Dwiprahasto I
    Asian Pac J Cancer Prev; 2018 Jul; 19(7):1747-1752. PubMed ID: 30049182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can machine learning algorithms accurately predict discharge to nonhome facility and early unplanned readmissions following spinal fusion? Analysis of a national surgical registry.
    Goyal A; Ngufor C; Kerezoudis P; McCutcheon B; Storlie C; Bydon M
    J Neurosurg Spine; 2019 Oct; 31(4):568-578. PubMed ID: 31174185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort.
    Gayet M; Mannaerts CK; Nieboer D; Beerlage HP; Wijkstra H; Mulders PFA; Roobol MJ
    Eur Urol Focus; 2018 Mar; 4(2):228-234. PubMed ID: 28753781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation and validation of different machine-learning models in mortality prediction of trauma in motorcycle riders: a cross-sectional retrospective study in southern Taiwan.
    Kuo PJ; Wu SC; Chien PC; Rau CS; Chen YC; Hsieh HY; Hsieh CH
    BMJ Open; 2018 Jan; 8(1):e018252. PubMed ID: 29306885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving multivariable prostate cancer risk assessment using the Prostate Health Index.
    Foley RW; Gorman L; Sharifi N; Murphy K; Moore H; Tuzova AV; Perry AS; Murphy TB; Lundon DJ; Watson RW
    BJU Int; 2016 Mar; 117(3):409-17. PubMed ID: 25847734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 17-Gene Genomic Prostate Score Assay Provides Independent Information on Adverse Pathology in the Setting of Combined Multiparametric Magnetic Resonance Imaging Fusion Targeted and Systematic Prostate Biopsy.
    Salmasi A; Said J; Shindel AW; Khoshnoodi P; Felker ER; Sisk AE; Grogan T; McCullough D; Bennett J; Bailey H; Lawrence HJ; Elashoff DA; Marks LS; Raman SS; Febbo PG; Reiter RE
    J Urol; 2018 Sep; 200(3):564-572. PubMed ID: 29524506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the predictive accuracy and the clinical benefit of a nomogram aimed to predict survival in node-positive prostate cancer patients: External validation on a multi-institutional database.
    Bianchi L; Schiavina R; Borghesi M; Bianchi FM; Briganti A; Carini M; Terrone C; Mottrie A; Gacci M; Gontero P; Imbimbo C; Marchioro G; Milanese G; Mirone V; Montorsi F; Morgia G; Novara G; Porreca A; Volpe A; Brunocilla E
    Int J Urol; 2018 Jun; 25(6):574-581. PubMed ID: 29633372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of breast cancer risk with volatile biomarkers in breath.
    Phillips M; Cataneo RN; Cruz-Ramos JA; Huston J; Ornelas O; Pappas N; Pathak S
    Breast Cancer Res Treat; 2018 Jul; 170(2):343-350. PubMed ID: 29569019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes.
    Alves de Inda M; van Strijp D; den Biezen-Timmermans E; van Brussel A; Wrobel J; van Zon H; Vos P; Baillie GS; Tennstedt P; Schlomm T; Houslay MD; Bangma C; Hoffmann R
    Eur Urol Focus; 2018 Apr; 4(3):376-384. PubMed ID: 28753810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential tissue-specific cancer biomarkers and development of cancer versus normal genomic classifiers.
    Mohammed A; Biegert G; Adamec J; Helikar T
    Oncotarget; 2017 Oct; 8(49):85692-85715. PubMed ID: 29156751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptation of a Biomarker-Based Sepsis Mortality Risk Stratification Tool for Pediatric Acute Respiratory Distress Syndrome.
    Yehya N; Wong HR
    Crit Care Med; 2018 Jan; 46(1):e9-e16. PubMed ID: 28991832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.
    Van Neste L; Hendriks RJ; Dijkstra S; Trooskens G; Cornel EB; Jannink SA; de Jong H; Hessels D; Smit FP; Melchers WJ; Leyten GH; de Reijke TM; Vergunst H; Kil P; Knipscheer BC; Hulsbergen-van de Kaa CA; Mulders PF; van Oort IM; Van Criekinge W; Schalken JA
    Eur Urol; 2016 Nov; 70(5):740-748. PubMed ID: 27108162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A predictive model for high/low risk group according to oncotype DX recurrence score using machine learning.
    Kim I; Choi HJ; Ryu JM; Lee SK; Yu JH; Kim SW; Nam SJ; Lee JE
    Eur J Surg Oncol; 2019 Feb; 45(2):134-140. PubMed ID: 30348602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.
    Zou M; Liu Z; Zhang XS; Wang Y
    Bioinformatics; 2015 Oct; 31(20):3330-8. PubMed ID: 26092859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker enhanced risk prediction for development of AKI after cardiac surgery.
    Merchant ML; Brier ME; Slaughter MS; Klein JB; McLeish KR
    BMC Nephrol; 2018 May; 19(1):102. PubMed ID: 29720115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.